...
首页> 外文期刊>Memo - Magazine of European medical oncology >Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: meeting report of the EC-funded science-communication project DIRECT 'Overcoming Cancer with Research'
【24h】

Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: meeting report of the EC-funded science-communication project DIRECT 'Overcoming Cancer with Research'

机译:迫切需要欧洲共同体继续支持欧洲儿科肿瘤学的未来发展:欧洲共同体资助的科学传播项目直接报告“通过研究克服癌症”的会议报告

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Purpose: Remarkable advances in paediatric cancer research and treatment were achieved during the last decades: In industrialised nations, overall cure rates were raised from below 20% to over 75% during the last forty years. Randomised investigator-driven clinical trials have been the backbone of this progress so far. The EU Clinical Trial Directive was introduced to improve the quality and safety of drug development; however, it has created considerable administrative "extra" workload as well as financial constraints for trials aiming at cancer treatment optimisation in children. It failed to provide harmonisation for clinical trials throughout Europe because translation into national law was highly divergent. To address the resulting challenges for future advances in European paediatric oncology including the promotion of new drug development, improved communication between all stakeholders is warranted.
机译:背景/目的:在过去的几十年中,儿科癌症研究和治疗取得了显着进展:在工业化国家中,过去40年中,总治愈率从20%以下提高到75%以上。迄今为止,由研究人员驱动的随机临床试验一直是这一进展的基础。引入了欧盟临床试验指令以提高药物开发的质量和安全性;然而,它为旨在优化儿童癌症治疗的试验创造了可观的行政“额外”工作量以及财务限制。它未能为整个欧洲的临床试验提供统一性,因为翻译成国家法律的分歧很大。为了应对欧洲儿科肿瘤学未来进展(包括促进新药开发)带来的挑战,必须保证所有利益相关者之间的交流更加畅通。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号